Fact CheckerSign in

NCT05443412Recruiting

Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection

Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection: A Synergy of Novel Biomarkers, Advanced Imaging, and Robotic-assisted Diagnosis

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

This is a prospective clinical study recruiting 510 men at risk of PCa to undergo urine, blood, AI-assisted ultrasound and AI-assisted MRI investigations to stratify risk of clinically significant PCa (csPCa). (sample size calculation in section 5)

Status (registry)
Recruiting
Study type
Observational
Enrollment
510 (estimated)
First submitted
22 Jun 2022
Start date
1 Aug 2023
Primary completion date
31 Dec 2028
Lead sponsor
Chinese University of Hong Kong
NCT number
NCT05443412

What you commit to

  • Study type: Observational
  • Planned participants: 510
  • From 1 Aug 2023 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior prostate biopsy

Other illness

  • Past or current history of prostate cancer
  • Contraindicated to transperineal prostate biopsy: active urinary tract infection, fail TRUS probe insertion or lithotomy position, uncorrectable coagulopathy, antiplatelet or anticoagulant which cannot be stopped

Other

  • Contraindicated to undergo plain MRI scan (e.g. pacemaker in-situ, claustrophobia)

Who the study is looking for

  • Men ≥18 years of age
  • Clinical suspicion of prostate cancer
  • Serum Prostate-specific antigen (PSA) 4-20 ng/mL
  • Digital rectal examination ≤ cT2 (organ confined cancer)
  • Able to provide written informed consent

Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prince of Wales Hospital, Chinese University of Hong Kong
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.